All Viruses articles
-
NewsCancer drug repurposed to treat drug-resistant herpes
Researchers have successfully repurposed an FDA-approved cancer drug, doxorubicin, to treat drug-resistant strains of herpes. A digital tool that combs through chemical compounds and flags those that may be effective against herpes infections, identified doxorubicin, a known anticancer drug.
-
NewsGlobal Virus Network awards education and training grants to advance next-generation virology research and pandemic preparedness
The Global Virus Network (GVN) today announced the recipients of $90,000 in 2025 Education and Training Grants, supporting emerging scientists and institutions advancing translational virology, genomic surveillance, data-driven preparedness, and global health equity.
-
NewsNew research suggests HIV can be kept in check – without medication
An international study shows that a combination of two parts of the immune system – antibodies and T cells – can suppress HIV without lifelong medication.
-
NewsResearchers reveal m6A epigenetic modification controls arbovirus infection and transmission between vertebrates and mosquitoes
Researchers reveal that N6-methyladenosine (m6A) epigenetic modifications in mosquito-borne flaviviruses (MBFs) enhance viral propagation in vertebrates and thus increase transmission from vertebrates to mosquitoes.
-
NewsHKU innovations achieve recognition at the 51st International Exhibition of Inventions at Geneva
The University of Hong Kong (HKU) secured 46 awards at the 51st International Exhibition of Inventions of Geneva, including recognition for a project aiming to gain immunity against the three major respiratory viruses through home-based toothbrushing.
-
NewsStudy details neuropsychiatric symptoms and biological mechanisms of long COVID
A review highlights the need to standardize diagnosis and treatment of long Covid. In the study, the researchers emphasize that avoiding SARS-CoV-2 infection is the only way to prevent long COVID so far.
-
NewsWhy some people naturally control HIV even after stopping therapy — and how we can leverage that to treat others
New research offers a path toward life without daily HIV pills, suggesting a common diabetes pill could help achieve long-term remission.
-
NewsNew study reveals spleen-to-lung neutrophil axis orchestrates antiviral defense
Single-cell spatial mapping uncovers the spleen as a critical reservoir for lung neutrophils during respiratory viral infection, according to a new study.
-
NewsPromising active substance against hepatitis E identified
A drug that is already in clinical trials against hepatitis C virus can also prevent hepatitis E virus from replicating An international research team has filtered bemnifosbuvir, a nucleotide/nucleoside analogue, out of a library of active substances.
-
NewsTarget behind cancer drug shown to help fight influenza in mice
A protein already targeted by FDA-approved cancer drugs may also help the body fight influenza. A study found that Programmed Death-Ligand 1 (PD-L1), best known for helping tumors evade immune attack, instead helped immunocompromised mice clear flu-infected lung cells and survive infection.
-
NewsBird flu risk to Danish cattle – new tool can warn farmers before infection spreads
Researchers have developed a tool that can predict where and when the risk of infection is highest. The tool is based on infection data from the U.S. outbreaks and adapted to a Danish context.
-
NewsScientists uncover how HPV-positive cancers hide from the immune system — and how to make them visible again
A new study solves a major mystery in cancer immunology by uncovering how HPV hides cancer cells from the immune system by using MARCHF8 to destroy MHC-I, which serves as a warning flag for the immune system.
-
NewsNovel biosensing platform enables fingertip blood-based micro-volume t-cell immune monitoring
A new platform, known as Tip Optofluidic Immunoassay Interferon-Gamma Release Assay (TOI-IGRA), could revolutionize how people monitor their immune health. The platform allows for the precise quantification of pathogen-specific T-cell responses using a mere 15-25 μL of fingertip blood.
-
NewsScientists discover a bacterium that protects against long Covid
Scientists have discovered the key role played by a bacterium, Dolosigranulum pigrum, that is naturally present in the respiratory microbiome. When present in greater numbers, these bacteria are associated with a reduction in the persistence of symptoms characteristic of long Covid.
-
NewsInappropriate antibiotic use for COVID-19 is linked to resistance
Taking azithromycin for as little as one day triggers antibiotic resistance in the respiratory tract, according to a first-of-its kind look by scientists at the changes that occur in the microbiome of hospitalized patients who were treated for COVID-19.
-
NewsClimate change is fueling disease outbreaks
Researchers analyzed the connection between a cyclone in Peru and a massive outbreak of dengue fever, a mosquito-borne viral disease that can cause fever, rash, and life-threatening symptoms like hemorrhage and shock. Their findings reveal that warmer, wetter weather linked to climate change is making disease epidemics more likely.
-
NewsWhat factors influence likelihood and severity of Ebola outbreaks?
Two new papers looked at factors that contribute to how Ebola outbreaks begin and how severe they become. This Q&A looks at how the results could inform public health interventions to prevent pathogen emergence or slow the spread of Ebola and other infectious diseases.
-
NewsTargeting two flu proteins sharply reduces airborne spread
A study in ferrets — which have remarkably similar respiratory systems to humans — suggests that immunity to two proteins in the H1N1 influenza virus sharply reduces transmission.
-
NewsScientists reveal how deadly Marburg virus enters human cells, identify therapeutic vulnerability
Researchers found that the Marburg virus, one of the world’s deadliest pathogens, is unusually efficient at getting inside human cells. They also showed that the virus’s entry protein contains structural features that explain this efficiency and point to a strategy for blocking infection.
-
NewsHow one flu virus can hamper the immune response to another
Prior exposure to one strain of influenza virus may weaken children’s ability to mount an effective antibody response against their subsequent exposure to a different flu strain, according to a study.